What are India’s most eminent life science individuals saying about CSIR?

Updated on 21 November 2012

Read what some of India’s most eminent individuals belonging to the life sciences sector have to say about the country’s flagship science organization, CSIR, and its accomplishments

what-they-are-saying-about-india-csir1

(Clockwise from top, L-R): Dr YK Hamied, chairman, Cipla; Dr Prabuddha Kundu, executive director, Premas Biotech; Dr Girish Sahni, director, Institute of Microbial Technology (IMTECH), Chandigarh ; Mr Valayar Ravi, former minister of science and technology, Government of India; Dr Ch Mohan Rao, director, Centre for Cell and Molecular Biology (CCMB), Hyderabad; Dr Manmohan Singh, Prime Minister of India; and Dr Rajesh Gokhale, director, Institute of Genomics and Integrative Biology (IGIB), New Delhi

India's Council of Scientific and Industrial Research (CSIR), which was established in 1942 as an autonomous society and with 37 state-of-the-art institutes by Dr Shanti Swarup Bhatnagar, has come a long way since its inception 70 years ago and is considered to be one of the foremost research organizations in the world. Read what some of India's most eminent individuals have to say about the country's flagship science organization.

"I compliment CSIR for breakthroughs in advanced scientific areas that have the potential to meet the basic needs of our people."
- Dr Manmohan Singh, Prime Minister of India

"CSIR has transformed itself many times; yet its all pervading spirit remains unchanged and dedicated service to the nation and the amelioration of the conditions of citizens remains its guiding light. Young at 70, CSIR is pursuing the quest for inclusivity in many innovative and novel ways."
- Mr Valayar Ravi, former minister of science and technology, Government of India

"Under the current global scenario, our major challenge is to discover new drugs. CSIR has outstanding laboratories for chemical synthesis of new molecular entities. Our biology laboratories working with the chemical laboratories should be able to meet the challenge. However, future medicine would be largely based on cells rather than molecules. CCMB and a few other biology laboratories of CSIR are working on cell-based therapies including stem cells for diseases important to our country".
- Dr Ch Mohan Rao, director, Centre for Cell and Molecular Biology (CCMB), Hyderabad

"CSIR's relevance on the national scene has become even more pronounced as it is perhaps the only institution that so successfully straddles both fundamental and applications aspects of science. This is particularly so in the transformation of biological principles into biotechnology, where CSIR has already made major outstanding contributions.
- Dr Girish Sahni, director, Institute of Microbial Technology (IMTECH), Chandigarh

 

Previous 1

Leave a Reply

Notify me of follow-up comments via e-mail address

Post Comment

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X